DealBook: Bristol-Myers to Buy Inhibitex for $2.5 Billion

Under the terms of the deal, Bristol-Myers will pay $26 a share, an enormous 163 percent premium over Inhibitex’s Friday closing price.

More here:
DealBook: Bristol-Myers to Buy Inhibitex for $2.5 Billion


Comments are closed.